Diagnostic value of soluble urokinase receptor serum levels in adults with idiopathic nephrotic syndrome;Valor diagnóstico de los niveles séricos del receptor soluble de la uroquinasa en adultos con síndrome nefrótico idiopático

Nefrologia

Volumn 34, Issue 1, 2014, Pages 46-52

  Segarra, Alfons ^a   Jatem, Elías ^b   Quiles, M Teresa ^c   Arbós, M Antonia ^c   Ostos, Helena ^a   Valtierra, Naiara ^a   Carnicer, Clara ^a   Agraz, Irene ^a   Salcedo, M Teresa ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Glomerulosclerosis segmentary and focal; Nephrotic syndrome; suPAR

Indexed keywords

UROKINASE RECEPTOR;

ADULT; BLOOD; FEMALE; HUMAN; MALE; MIDDLE AGED; NEPHROTIC SYNDROME;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR;

EID: 84894364914     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2013.Oct.12256     Document Type: Article

References (19)

1. Quereda C, Ballarín J. Síndrome nefrótico por glomerulosclerosis focal segmentaria del adulto. Nefrologia 2007;27(Suppl 2):56-69.
2. Appel AS, D'Agati VD. Primary and secondary (non-genetic) causes of focal and segmental glomerulosclerosis. In: Floege J, Johnson RJ, Feehally J (eds.). Comprehensive clinical nephrology (4th ed.). St. Louis: Elsevier Saunders; 2010. p. 228-40.
3. Meyrier A. Management of idiopathic nephrotic syndrome in adults: minimal change disease and focal segmental glomerulosclerosis. In: Molony DA, Craig JC (eds.). Evidence-based nephrology (4th ed.). Oxford: Wiley-Blackwell; 2009. p. 149-57.
4. Hickson LJ, Gera M, Amer H, Iqbal CW, Moore TB, Milliner DS, et al. Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence. Transplantation 2009;87:1232-9.
5. Artero ML, Sharma R, Savin VJ, Vincenti F. Plasmapheresis reduces proteinuriaand serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994;23:574-81.
6. Haas M, Godfrin Y, Oberbauer R, Yilmaz N, Borchhardt K, Regele H, et al. Plasma immunadsorption treatment in patients with primary focal and segmental glomerulosclerosis. Nephrol Dial Transplant 1998;13:2013-6.
7. Kemper MJ, Wolf G, Müller-Wiefel DE. Transmission of glomerular permeability factor from a mother to her child. N Engl J Med 2001;344:386-7.
8. Wei CL, Cheung W, Heng CK, Arty N, Chong SS, Lee BW, et al. Interleukin-13 genetic polymorphisms in Singapore Chinese children correlate with long-term outcome of minimal-change disease. Nephrol Dial Transplant 2005;20:728-34.
9. van den Berg JG, Aten J, Anwar Chand M, Claessen N, Dijkink L, Wijdenes J, et al. Interleukin-4 and interleukin-13 act on glomerular visceral epithelial cells. J Am Soc Nephrol 2000;11:413-22.
10. Lai KW, Wei CL, Tan LK, Tan PH, Chiang GS, Lee CG, et al. Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol 2007;18:1476-85.
11. Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 2011;17:952-60.
12. Maas RJ, Wetzels JF, Deegens JK. Serum-soluble urokinase receptor concentration in primary FSGS. Kidney Int 2012;81:1043-4.
13. Bock ME, Price HE, Gallon L, Langman CB. Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report. Clin J Am Soc Nephrol 2013;8(8):1304-11.
14. Wei C, Trachtman H, Li J, Dong C, Friedman AL, Gassman JJ, et al. Circulating suPAR in Two Cohorts of Primary FSGS. J Am Soc Nephrol 2012;23:2051-9.
15. Huang J, Lui G, Zhang YM, Cui Z, Wang F, Lui XJ, et al. Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis. Kidney Int 2013;84:366-72.
16. Maas RJ, Deegens JK, Wetzels JF. Serum suPAR in patients with FSGS: trash or treasure? Pediatr Nephrol 2013;28(7):1041-8.
17. Levey AS, Stevens SA, Schmid CH, Zhang Y, Castro III A, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12.
18. Qin W, Beck LH Jr, Zeng C, Chen Z, Li S, Zuo K, et al. Antiphospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 2011;22(6):1137-43.
19. Hoxha E, Harendza S, Zahner G, Panzer U, Steinmetz O, Fechner K, et al. An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 2011;26(8):2526-32.